This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (April 20, 2018).

Merck KGaA's products include Femibion, a supplement for women. A Business News article in some editions Thursday about the sale of Merck KGaA's consumer-health unit to Procter & Gamble Co. incorrectly called the product Febimion.

Readers can alert The Wall Street Journal to any errors in news articles by emailing wsjcontact@wsj.com or by calling 888-410-2667.

(END) Dow Jones Newswires

April 20, 2018 02:47 ET (06:47 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Procter and Gamble Charts.
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Procter and Gamble Charts.